Industry payments to Utah providers
Source: CMS Open Payments 2025 general payments by recipient state, company-reported. Payments do not imply wrongdoing and are separate from Medicare billing.
The top 40 companies paid $21,908,055 to Utah recipients in 2025.
Royalty / license: $7,318,012Speaker / faculty: $7,228,598Consulting: $6,801,652Food & beverage: $3,438,927Travel & lodging: $2,142,693Grant: $1,979,633Space rental or facility fees (teachin…: $667,505Debt forgiveness: $644,895
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation | 1,840 | $2,076,118 |
| ABBVIE INC. | 19,304 | $1,827,603 |
| ORTHO DEVELOPMENT CORPORATION | 201 | $1,794,728 |
| DePuy Synthes Products, Inc. | 45 | $1,729,454 |
| Zimmer Biomet Holdings, Inc. | 416 | $1,507,190 |
| Boston Scientific Corporation | 4,779 | $1,105,796 |
| Arthrex, Inc. | 515 | $979,364 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1,422 | $826,042 |
| Smith+Nephew, Inc. | 403 | $727,271 |
| INTUITIVE SURGICAL, INC. | 954 | $618,296 |
| AstraZeneca Pharmaceuticals LP | 3,127 | $453,948 |
| LEO Pharma Inc. | 386 | $421,428 |
| BioMarin Pharmaceutical Inc. | 46 | $410,598 |
| Medtronic, Inc. | 3,289 | $408,763 |
| Amgen Inc. | 4,278 | $404,700 |
| Change Healthcare Technologies, LLC | 1 | $400,864 |
| Galderma Laboratories, L.P. | 1,155 | $366,864 |
| UCB, Inc. | 1,489 | $365,049 |
| Lilly USA, LLC | 3,237 | $361,476 |
| Abbott Laboratories | 1,530 | $351,313 |
| Catalyst OrthoScience | 18 | $291,838 |
| PFIZER INC. | 4,661 | $285,264 |
| Janssen Scientific Affairs, LLC | 93 | $272,119 |
| GENZYME CORPORATION | 1,535 | $272,013 |
| Regeneron Pharmaceuticals, Inc. | 39 | $268,447 |
| GlaxoSmithKline, LLC. | 2,114 | $268,063 |
| OrthoPediatrics Corp. | 13 | $266,281 |
| COLOPLAST CORP | 133 | $257,765 |
| Route 92 Medical, Inc. | 8 | $239,917 |
| Medical Device Business Services, Inc. | 296 | $235,698 |
| CSL Plasma Inc. | 165 | $234,240 |
| Align Technology, Inc. | 597 | $222,457 |
| Edwards Lifesciences Corporation | 575 | $219,524 |
| Janssen Biotech, Inc. | 2,321 | $211,270 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1,891 | $208,587 |
| Novartis Pharmaceuticals Corporation | 3,020 | $208,391 |
| SANOFI-AVENTIS U.S. LLC | 668 | $206,687 |
| Regeneron Healthcare Solutions, Inc. | 1,342 | $203,476 |
| Olympus Corporation of the Americas | 13 | $203,012 |
| Neurocrine BioSciences, Inc. | 1,071 | $196,141 |
"Who does it pay?" opens the List Builder: free count and top 3 recipients, full list with addresses and phone for $29 or included with membership.
